Brief: Akari Therapeutics PLC Files For Mixed Shelf Of Up To $75 Million – SEC Filing
29/07/2025 22:35
Akari Therapeutics PLC AKTX.O: AKARI THERAPEUTICS PLC FILES FOR MIXED SHELF OF UP TO $75 MILLION – SEC FILING Source text: [ID:n0001641172-25-021425] Further company coverage: AKTX.O
Recent news on Akari Therapeutics
See all newsBrief: Akari Therapeutics - Aktx-101 Demonstrates Robust Anti-Tumor Activity In Urothelial Cancer Preclinical Models
UK's Akari Therapeutics Q2 net loss widens on higher R&D for AKTX-101
Akari Therapeutics PLC reports results for the quarter ended June 30 - Earnings Summary
Akari Therapeutics PLC expected to post a loss of $1.40 a share - Earnings Preview
Brief: Akari Therapeutics Enters Strategic Research Collaboration With Whitehawk Therapeutics